Genmab — December 2023
-
JB: "Genmab
• Aktien har været under pres MEN god opsamlingsmulighed
• R&D-dag 12. december kan være en positiv trigger med fokus på lanceringen af EPKINLY (lymfekræft) og opdateret data for Hexabody-CD38 (knoglemarvskræft)
• J&J udnytter optionen og bliver partner på Hexabody-CD38" -
Kræftramt René Henriksen har fået sit gamle liv tilbage
Den tidligere fodboldspiller René Henriksen føler, at han er født på ny, selv om han er ramt af kræft.
sport.tv2.dk (sport.tv2.dk)
-
Amgen Creates New Therapy Line --for rare disease therapies. https://www.sfvbj.com/healthcare/am -- Chief among those drugs is Tepezza,
gen-creates-new-therapy-line/ -
Ugens aktie: Genmab lover store fremskridt i udviklingsporteføljen https://finans.dk/privatokonomi/ECE16655232/ugens-aktie-genmab-lover-store-fremskridt-i-udviklingsportefoeljen/
-
Malign aktivitet ved car-t: https://haematologisktidsskrift.dk/sygdomme/1278-fda-mistaenker-malign-aktivitet-efter-car-t-behandling.html
-
Georgetown University trying Dara in lung cancer with - With KRAS Vaccine and Anti-PD-1 Antibody in Subjects With Pancreatic Ductal Adenocarcinoma and Refractory Non-Small Cell Lung Cancer (DARANIVOVAX) https://clinicaltrials.gov/study/NCT06015724
-
ESMO Asia 2023 – deaths raise doubts about Merus’s Rybrevant challenger https://www.oncologypipeline.com/apexonco/esmo-asia-2023-deaths-raise-doubts-about-meruss-rybrevant-challenger
-
Godmorgen
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind